Glaxosmithkline AS is a Norwegian AS based in Oslo, operating in the Wholesale of pharmaceutical and medical goods sector. Incorporated in 1981, the company has 74 employees and reported revenue of NOK 1.3bn in its latest annual filing.
In its most recent annual report (2025), Glaxosmithkline AS reported revenue of NOK 1.3bn, an increase of 22% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net profit of NOK 29.1m, and the EBITDA margin stood at 3.1%.
At the end of 2025, equity financed 28% of the balance sheet, and current assets covered short-term debt 1.1 times.
Frequently asked questions
What is the Org number of Glaxosmithkline AS?
Glaxosmithkline AS is registered with Brønnøysundsregistrene under Org 930606308.
What is the revenue of Glaxosmithkline AS?
Glaxosmithkline AS reported revenue of NOK 1.3bn in 2025.
How many employees does Glaxosmithkline AS have?
Glaxosmithkline AS employs 74 people as of the latest annual report.
Who is the CEO of Glaxosmithkline AS?
Omur Akalin Erin is the CEO of Glaxosmithkline AS, in role since 2023.
Who is the chairman of Glaxosmithkline AS?
Omur Akalin Erin chairs the board of Glaxosmithkline AS, in role since 2023.
Where is Glaxosmithkline AS headquartered?
Glaxosmithkline AS's registered address is Drammensveien 288.
